ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Eprosartan Meslyate
News »
latest
by relevance
Analysts give hot pharma picks for 2006
Oct 31, 2006 at 18:30
Pharma analysts tell Moneycontrol that cut in excise duty, a liberal new drug policy in April, drugs worth USD 25 billion coming off patent in 2006 and a USD 27 billion CRAMS market by 2010 will augur well for both domestic and MNC pharma companies.
Analysts give hot pharma picks for 2006
Oct 31, 2006 at 18:30
Pharma analysts tell Moneycontrol that cut in excise duty, a liberal new drug policy in April, drugs worth USD 25 billion coming off patent in 2006 and a USD 27 billion CRAMS market by 2010 will augur well for both domestic and MNC pharma companies.
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
/ 
/
/